Recent studies have reported that KDM6A showed more mutations in NMIBC in females than in males, and loss of KDM6A increases BLCA risks in female patients [31], indicating that KDM6A plays a decisive role in the gender difference in BLCA. This evidence concerns the gene KDM6A and bladder transitional cell carcinoma.